These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2444802)

  • 1. Hemodynamic effects at rest and during exercise of combined alpha/beta-receptor blockade and of beta-receptor blockade alone in patients with ischemic heart disease.
    Koch G; Fransson L
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):474-8. PubMed ID: 2444802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
    Koch G
    Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and adrenergic effects of combined alpha/beta-receptor blockade versus combined beta-receptor and slow channel calcium blockade in patients with ischemic heart disease.
    Koch G; Fransson L
    Int J Cardiol; 1989 Oct; 25(1):73-9. PubMed ID: 2793265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
    Koch G; Fransson L
    Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses.
    Prida XE; Hill JA; Feldman RL
    Am J Cardiol; 1987 May; 59(12):1084-8. PubMed ID: 2883869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Br Heart J; 1982 Oct; 48(4):364-71. PubMed ID: 7126388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease.
    Feldman RL; Prida XE; Lambert CR; Hill JA
    Cardiovasc Drugs Ther; 1988 Sep; 2(3):355-61. PubMed ID: 3155428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients.
    Koch G
    Am Heart J; 1977 May; 93(5):585-91. PubMed ID: 851058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Forsyth D; Taylor SH
    Eur Heart J; 1984 Jan; 5(1):67-79. PubMed ID: 6705807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests.
    Feldman RL; Prida XE; Hill JA
    Clin Cardiol; 1988 Jun; 11(6):383-8. PubMed ID: 3396239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of metoprolol and celiprolol on cardiac hemodynamics and left ventricular volume at rest and during exercise-induced angina.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Clin Pharmacol Ther; 1986 Jan; 39(1):5-14. PubMed ID: 2935349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic advantages of combined alpha-blockade and beta-blockade over beta-blockade alone in patients with coronary heart disease.
    Taylor SH; Silke B; Nelson GI; Okoli RC; Ahuja RC
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):325-7. PubMed ID: 6807469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
    Koch G
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of combined or separate alpha- and beta-blockade in the treatment of hypertension in the acute stage of myocardial infarction.
    Renard M; Jacobs P; Liebens I; Abou Hamdam B; Bernard R
    Int J Cardiol; 1986 Feb; 10(2):149-58. PubMed ID: 3080379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease.
    Burkart F; Pfisterer M; Steinmann E
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S78-82. PubMed ID: 2439804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE; Feldman RL; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
    Condorelli M; Brevetti G; Chiariello M; Miceli D; Lavecchia G; Paudice G; Verrienti S
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):101S-110S. PubMed ID: 7093092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.